Alternative Lengthening of Telomeres and Mediated Telomere Synthesis

Simple Summary Alternative lengthing of telomere (ALT) is an important mechanism for maintaining telomere length and cell proliferation in telomerase-negative tumor cells. However, the molecular mechanism of ALT is still poorly understood. ALT occurs in a wide range of tumor types and usually associated with a worse clinical consequence. Here, we review the recent findings of ALT mechanisms, which promise ALT could be a valuable drug target for clinical telomerase-negative tumor treatment. Abstract Telomeres are DNA–protein complexes that protect eukaryotic chromosome ends from being erroneously repaired by the DNA damage repair system, and the length of telomeres indicates the replicative potential of the cell. Telomeres shorten during each division of the cell, resulting in telomeric damage and replicative senescence. Tumor cells tend to ensure cell proliferation potential and genomic stability by activating telomere maintenance mechanisms (TMMs) for telomere lengthening. The alternative lengthening of telomeres (ALT) pathway is the most frequently activated TMM in tumors of mesenchymal and neuroepithelial origin, and ALT also frequently occurs during experimental cellular immortalization of mesenchymal cells. ALT is a process that relies on homologous recombination (HR) to elongate telomeres. However, some processes in the ALT mechanism remain poorly understood. Here, we review the most recent understanding of ALT mechanisms and processes, which may help us to better understand how the ALT pathway is activated in cancer cells and determine the potential therapeutic targets in ALT pathway-stabilized tumors.

[1]  J. Lingner,et al.  The makings of TERRA R-loops at chromosome ends , 2021, Cell cycle.

[2]  Z. Songyang,et al.  TRIM28 inhibits alternative lengthening of telomere phenotypes by protecting SETDB1 from degradation , 2021, Cell & bioscience.

[3]  V. Uversky,et al.  The Role of Non-Specific Interactions in Canonical and ALT-Associated PML-Bodies Formation and Dynamics , 2021, International journal of molecular sciences.

[4]  R. Bjerkvig,et al.  A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cells , 2021, Science Translational Medicine.

[5]  Dong Zhang,et al.  ALT Positivity in Human Cancers: Prevalence and Clinical Insights , 2021, Cancers.

[6]  U. Ghosh,et al.  PARP1 modulates telomere sister chromatid exchange and telomere length homeostasis by regulating telomere localization of SLX4 in U2OS cells. , 2021, Life sciences.

[7]  L. Zou,et al.  Alternative lengthening of telomeres is a self-perpetuating process in ALT-associated PML bodies. , 2021, Molecular cell.

[8]  Joanna R. Morris,et al.  A fork in the road: Where homologous recombination and stalled replication fork protection part ways , 2020, Seminars in cell & developmental biology.

[9]  R. Greenberg,et al.  Nuclear body phase separation drives telomere clustering in ALT cancer cells , 2020, Molecular biology of the cell.

[10]  R. L. Flynn,et al.  RAD54 promotes alternative lengthening of telomeres by mediating branch migration , 2020, EMBO reports.

[11]  E. L. Denchi,et al.  Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres , 2020, bioRxiv.

[12]  D. Piccini,et al.  Telomere damage induces internal loops that generate telomeric circles , 2020, Nature Communications.

[13]  Xu-Dong Zhu,et al.  CSB cooperates with SMARCAL1 to maintain telomere stability in ALT cells , 2020, Journal of Cell Science.

[14]  Kaori Takai,et al.  ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity , 2020, PLoS biology.

[15]  H. Pickett,et al.  FANCM suppresses DNA replication stress at ALT telomeres by disrupting TERRA R-loops , 2019, Scientific Reports.

[16]  J. Shay,et al.  Clustered telomeres in phase-separated nuclear condensates engage mitotic DNA synthesis through BLM and RAD52 , 2019, Genes & development.

[17]  C. Azzalin,et al.  FANCM limits ALT activity by restricting telomeric replication stress induced by deregulated BLM and R-loops , 2019, Nature Communications.

[18]  R. F. Luco,et al.  SETDB1-dependent heterochromatin stimulates alternative lengthening of telomeres , 2019, Science Advances.

[19]  H. Pickett,et al.  The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT) , 2019, Nature Communications.

[20]  Zepeng Zhang,et al.  Strand break-induced replication fork collapse leads to C-circles, C-overhangs and telomeric recombination , 2019, PLoS genetics.

[21]  R. Greenberg,et al.  RAD52 and SLX4 act nonepistatically to ensure telomere stability during alternative telomere lengthening , 2019, Genes & development.

[22]  L. Zou,et al.  Alternative Lengthening of Telomeres through Two Distinct Break-Induced Replication Pathways , 2019, Cell reports.

[23]  F. Berardinelli,et al.  Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT) , 2018, International journal of molecular sciences.

[24]  M. A. Vega-Palas,et al.  Epigenetic features of human telomeres , 2018, Nucleic acids research.

[25]  C. Leonetti,et al.  Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option? , 2017, Journal of experimental & clinical cancer research : CR.

[26]  J. Déjardin,et al.  Telomere chromatin establishment and its maintenance during mammalian development , 2017, Chromosoma.

[27]  H. Pickett,et al.  Alternative Lengthening of Telomeres: DNA Repair Pathways Converge. , 2017, Trends in genetics : TIG.

[28]  Zepeng Zhang,et al.  A Cisplatin Derivative Tetra-Pt(bpy) as an Oncotherapeutic Agent for Targeting ALT Cancer , 2017, Journal of the National Cancer Institute.

[29]  H. Pickett,et al.  BLM and SLX4 play opposing roles in recombination‐dependent replication at human telomeres , 2017, The EMBO journal.

[30]  J. Shay,et al.  Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes , 2017, Molecular and Cellular Biology.

[31]  C. Schildkraut,et al.  FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres , 2017, Proceedings of the National Academy of Sciences.

[32]  Chenhui Huang,et al.  The human CTC1/STN1/TEN1 complex regulates telomere maintenance in ALT cancer cells , 2017, Experimental Cell Research.

[33]  M. Mann,et al.  Phylointeractomics reconstructs functional evolution of protein binding , 2017, Nature Communications.

[34]  Callen T. Wallace,et al.  Proteomic Profiling Reveals a Specific Role for Translesion DNA Polymerase η in the Alternative Lengthening of Telomeres , 2016, Cell reports.

[35]  R. Greenberg,et al.  Break-induced telomere synthesis underlies alternative telomere maintenance , 2016, Nature.

[36]  S. Gagos,et al.  Alternative lengthening of human telomeres is a conservative DNA replication process with features of break‐induced replication , 2016, EMBO reports.

[37]  D. Bazett-Jones,et al.  FANCD2 limits BLM-dependent telomere instability in the alternative lengthening of telomeres pathway. , 2016, Human molecular genetics.

[38]  A. D’Andrea,et al.  FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair. , 2016, Cell reports.

[39]  Joao Matos,et al.  Cell cycle control of DNA joint molecule resolution. , 2016, Current opinion in cell biology.

[40]  J. Shay,et al.  Role of Telomeres and Telomerase in Aging and Cancer. , 2016, Cancer discovery.

[41]  A. Sfeir,et al.  Stop pulling my strings — what telomeres taught us about the DNA damage response , 2016, Nature Reviews Molecular Cell Biology.

[42]  R. L. Flynn,et al.  SMARCAL1 Resolves Replication Stress at ALT Telomeres , 2016, Cell reports.

[43]  C. M. Eischen,et al.  SMARCAL1 maintains telomere integrity during DNA replication , 2015, Proceedings of the National Academy of Sciences.

[44]  R. Greenberg,et al.  ALTernative Telomere Maintenance and Cancer. , 2015, Trends in cancer.

[45]  P. Sung,et al.  Biochemical mechanism of DSB end resection and its regulation. , 2015, DNA repair.

[46]  D. Higgs,et al.  Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX , 2015, Nature Communications.

[47]  M. Lei,et al.  SLX4 contributes to telomere preservation and regulated processing of telomeric joint molecule intermediates , 2015, Nucleic acids research.

[48]  R. Reddel,et al.  ATRX represses alternative lengthening of telomeres , 2015, Oncotarget.

[49]  J. Tainer,et al.  Envisioning the dynamics and flexibility of Mre11-Rad50-Nbs1 complex to decipher its roles in DNA replication and repair. , 2015, Progress in biophysics and molecular biology.

[50]  G. Almouzni,et al.  Assembly of telomeric chromatin to create ALTernative endings. , 2014, Trends in cell biology.

[51]  R. Greenberg,et al.  Interchromosomal Homology Searches Drive Directional ALT Telomere Movement and Synapsis , 2014, Cell.

[52]  Radhakrishnan Kanagaraj,et al.  DNA2 Cooperates with the WRN and BLM RecQ Helicases to Mediate Long-range DNA End Resection in Human Cells* , 2014, The Journal of Biological Chemistry.

[53]  J. Parvin,et al.  Association of BLM and BRCA1 during Telomere Maintenance in ALT Cells , 2014, PloS one.

[54]  R. Camerini-Otero,et al.  HOP2-MND1 modulates RAD51 binding to nucleotides and DNA , 2014, Nature Communications.

[55]  G. Almouzni,et al.  Rapid induction of Alternative Lengthening of Telomeres by depletion of the histone chaperone ASF1 , 2013, Nature Structural &Molecular Biology.

[56]  M. Tijsterman,et al.  Genomes and G-quadruplexes: for better or for worse. , 2013, Journal of molecular biology.

[57]  Xiaowei Zhuang,et al.  Super-Resolution Fluorescence Imaging of Telomeres Reveals TRF2-Dependent T-loop Formation , 2013, Cell.

[58]  I. Mihalek,et al.  TRF2 Interaction with Ku Heterotetramerization Interface Gives Insight into c-NHEJ Prevention at Human Telomeres , 2013, Cell reports.

[59]  David J. Chen,et al.  DNA double strand break repair via non-homologous end-joining. , 2013, Translational cancer research.

[60]  N. Royle,et al.  The roles of WRN and BLM RecQ helicases in the Alternative Lengthening of Telomeres , 2012, Nucleic acids research.

[61]  W. Hahn,et al.  Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway , 2012, PLoS genetics.

[62]  B. Eichman,et al.  SMARCAL1 catalyzes fork regression and Holliday junction migration to maintain genome stability during DNA replication. , 2012, Genes & development.

[63]  H. Leonhardt,et al.  De novo assembly of a PML nuclear subcompartment occurs through multiple pathways and induces telomere elongation , 2011, Journal of Cell Science.

[64]  E. Montgomery,et al.  Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. , 2011, The American journal of pathology.

[65]  R. McLendon,et al.  Altered Telomeres in Tumors with ATRX and DAXX Mutations , 2011, Science.

[66]  N. Volkow,et al.  Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain , 2011, Molecular Psychiatry.

[67]  M. Lopes,et al.  Rad51 protects nascent DNA from Mre11 dependent degradation and promotes continuous DNA synthesis , 2010, Nature Structural &Molecular Biology.

[68]  R. Reddel,et al.  Alternative lengthening of telomeres: models, mechanisms and implications , 2010, Nature Reviews Genetics.

[69]  R. Hannan,et al.  ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. , 2010, Genome research.

[70]  H. Pickett,et al.  Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions , 2009, Nature Structural &Molecular Biology.

[71]  Amy Y. M. Au,et al.  DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity , 2009, Nature Biotechnology.

[72]  L. Tomáška,et al.  Telomeric circles: universal players in telomere maintenance? , 2009, Nature Structural &Molecular Biology.

[73]  A. Ali,et al.  FANCM-FAAP24 and FANCJ: FA proteins that metabolize DNA. , 2009, Mutation research.

[74]  C. Schildkraut,et al.  Mammalian Telomeres Resemble Fragile Sites and Require TRF1 for Efficient Replication , 2009, Cell.

[75]  J. Yates,et al.  Human SLX4 Is a Holliday Junction Resolvase Subunit that Binds Multiple DNA Repair/Recombination Endonucleases , 2009, Cell.

[76]  J. Londoño-Vallejo,et al.  Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells , 2009, Oncogene.

[77]  Wilhelm Palm,et al.  Functional Dissection of Human and Mouse POT1 Proteins , 2008, Molecular and Cellular Biology.

[78]  R. Kanaar,et al.  The structure-specific endonuclease Mus81 contributes to replication restart by generating double-strand DNA breaks , 2007, Nature Structural &Molecular Biology.

[79]  Hongtao Yu,et al.  The SMC5/6 Complex Maintains Telomere Length in ALT Cancer Cells through Sumoylation of Telomere‐Binding Proteins , 2007 .

[80]  Sarah A. Compton,et al.  Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells. , 2007, Cancer research.

[81]  T. Lange,et al.  Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination , 2006, Nature Cell Biology.

[82]  J. Haber,et al.  Break-induced replication and recombinational telomere elongation in yeast. , 2006, Annual review of biochemistry.

[83]  A. Hong,et al.  The role of telomeres and telomerase in the pathology of human cancer and aging , 2006, Pathology.

[84]  M. Cerone,et al.  A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT , 2005, Oncogene.

[85]  R. Reddel,et al.  Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies. , 2005, Cancer research.

[86]  T. Lange,et al.  Homologous Recombination Generates T-Loop-Sized Deletions at Human Telomeres , 2004, Cell.

[87]  L. Cazes,et al.  Alternative Lengthening of Telomeres Is Characterized by High Rates of Telomeric Exchange , 2004, Cancer Research.

[88]  T. Jenuwein,et al.  Suv39h-Mediated Histone H3 Lysine 9 Methylation Directs DNA Methylation to Major Satellite Repeats at Pericentric Heterochromatin , 2003, Current Biology.

[89]  M. Ikura,et al.  The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. , 2002, Human molecular genetics.

[90]  R. Reddel,et al.  Telomere maintenance by recombination in human cells , 2000, Nature Genetics.

[91]  H. Wakimoto,et al.  Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors. , 2015, Science.

[92]  I. Draškovič,et al.  Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin , 2014, Nucleic acids research.

[93]  R. DePinho,et al.  Telomeres and telomerase in cancer. , 2010, Carcinogenesis.

[94]  P. Burgers,et al.  The PCNA-RFC families of DNA clamps and clamp loaders. , 2004, Progress in nucleic acid research and molecular biology.

[95]  M. Brenneman,et al.  Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. , 2004, Nucleic acids research.

[96]  T. Jacks,et al.  For Better or Worse? Minireview Telomerase Inhibition and Cancer , 1999 .